HOPE co-organizes with Eurordis a Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease Therapies.

The event will take place from 22 to 23 February 2017. It will bring together patient advocates, payers, HTA bodies, academics, clinicians, policy makers, investors and industry representatives to provide a platform for dialogue, a neutral ground and open environment for discussion.

All stakeholders will have the opportunity to express their views and observations in order to reach sustainable and durable solutions to improve patient access to rare disease therapies across Europe.

Download the preliminary programme.

Registrations are now open. For additional information please consult Eurordis Website.